Literature DB >> 22413082

Clinicopathologic factors affecting recurrence after curative surgery for stage I colorectal cancer.

Min Ae Keum1, Seok-Byung Lim, Sun A Kim, Yong Sik Yoon, Chan Wook Kim, Chang Sik Yu, Jin Cheon Kim.   

Abstract

PURPOSE: The objective of the current study was to identify the clinicopathological risk factors affecting recurrence after a curative resection for stage I colorectal cancer.
METHODS: We retrospectively studied 434 patients who underwent a curative resection for stage I colorectal cancer between January 1999 and December 2004. Postoperative oral chemotherapy was performed in 189 patients (45.3%). The following prognostic factors were correlated with recurrence: age, gender, preoperative carcinoembryonic antigen level, location of tumor, T stage, size of tumor, histologic differentiation, growth pattern, and lymphovascular invasion. The median follow-up duration was 65 months.
RESULTS: The overall recurrence rate was 4.6% (20/434). The median time to recurrence was 33 months. Two-thirds of the recurrence occurred more than two years after surgery. Risk factors associated with recurrence were rectal cancer (P = 0.009), T2 stage (P = 0.010), and infiltrative growth pattern (P = 0.020). A Cox proportional hazards regression analysis demonstrated that the infiltrative growth pattern was an independent predictor for recurrence. Tumor cell budding was observed in all pathologic reviews with recurrence.
CONCLUSION: Long-term follow-up is necessary for stage I colorectal patients with high risk factors like rectal cancer, T2 stage, and infiltrative growth pattern.

Entities:  

Keywords:  Colorectal neoplasms; Recurrence; Risk factors

Year:  2012        PMID: 22413082      PMCID: PMC3296942          DOI: 10.3393/jksc.2012.28.1.49

Source DB:  PubMed          Journal:  J Korean Soc Coloproctol        ISSN: 2093-7822


  25 in total

1.  Stage I rectal cancer: identification of high-risk patients.

Authors:  D Blumberg; P B Paty; A I Picon; J G Guillem; D S Klimstra; B D Minsky; S H Quan; A M Cohen
Journal:  J Am Coll Surg       Date:  1998-05       Impact factor: 6.113

Review 2.  Adjuvant therapy for colorectal cancer.

Authors:  A M Cohen; D Kelsen; L Saltz; B D Minsky; H Nelson; R Farouk; L L Gunderson; F Michelassi; R B Arenas; R L Schilsky; C G Willet
Journal:  Curr Probl Surg       Date:  1997-08       Impact factor: 1.909

3.  Incidence and patterns of recurrence after resection for cure of colonic cancer in a well defined population.

Authors:  S Manfredi; A M Bouvier; C Lepage; C Hatem; V Dancourt; J Faivre
Journal:  Br J Surg       Date:  2006-09       Impact factor: 6.939

4.  Clinical and pathological evaluation of patients with early and late recurrence of colorectal cancer.

Authors:  Mahdi Aghili; Shahrzad Izadi; Hossein Madani; Hossein Mortazavi
Journal:  Asia Pac J Clin Oncol       Date:  2010-03       Impact factor: 2.601

5.  Clinical features of colorectal cancer detected by the national cancer screening program.

Authors:  Dae-Do Park; Rumi Shin; Ji-Sun Kim; Heung-Kwon Oh; Seung-Yong Jeong; Kyu Joo Park; Jae-Gahb Park
Journal:  J Korean Soc Coloproctol       Date:  2010-12-31

6.  Tumour 'budding' as an index to estimate the potential of aggressiveness in rectal cancer.

Authors:  H Ueno; J Murphy; J R Jass; H Mochizuki; I C Talbot
Journal:  Histopathology       Date:  2002-02       Impact factor: 5.087

7.  Importance of tumor morphology for the long term prognosis of rectal adenocarcinoma.

Authors:  F Michelassi; L Vannucci; A Montag; R Goldberg; R Chappell; H Dytch; M Bibbo; G E Block
Journal:  Am Surg       Date:  1988-06       Impact factor: 0.688

8.  The role of venous and neural invasion on survival in rectal adenocarcinoma.

Authors:  A Horn; O Dahl; I Morild
Journal:  Dis Colon Rectum       Date:  1990-07       Impact factor: 4.585

9.  Prognostic value of tumor "budding" in patients with colorectal cancer.

Authors:  K Hase; C Shatney; D Johnson; M Trollope; M Vierra
Journal:  Dis Colon Rectum       Date:  1993-07       Impact factor: 4.585

10.  Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma.

Authors:  C G Moertel; T R Fleming; J S Macdonald; D G Haller; J A Laurie; P J Goodman; J S Ungerleider; W A Emerson; D C Tormey; J H Glick
Journal:  N Engl J Med       Date:  1990-02-08       Impact factor: 91.245

View more
  12 in total

1.  Preoperative carcinoembryonic antigen and prognosis of colorectal cancer. An independent prognostic factor still reliable.

Authors:  Giovanni Li Destri; Antonio Salvatore Rubino; Rosalia Latino; Fabio Giannone; Raffaele Lanteri; Beniamino Scilletta; Antonio Di Cataldo
Journal:  Int Surg       Date:  2015-04

2.  Pathological risk factors and predictive endoscopic factors for lymph node metastasis of T1 colorectal cancer: a single-center study of 846 lesions.

Authors:  Chihiro Yasue; Akiko Chino; Manabu Takamatsu; Ken Namikawa; Daisuke Ide; Shoichi Saito; Masahiro Igarashi; Junko Fujisaki
Journal:  J Gastroenterol       Date:  2019-02-27       Impact factor: 7.527

3.  Identification of Recurrence-Predictive Indicators in Stage I Colorectal Cancer.

Authors:  Jun Ho Lee; Jong Lyul Lee; In Ja Park; Seok-Byung Lim; Chang Sik Yu; Jin Cheon Kim
Journal:  World J Surg       Date:  2017-04       Impact factor: 3.352

4.  Factors affecting sphincter-preserving resection treatment for patients with low rectal cancer.

Authors:  Zhenqiang Sun; Xianbo Yu; Haijiang Wang; Ming Ma; Zeliang Zhao; Qisan Wang
Journal:  Exp Ther Med       Date:  2015-06-05       Impact factor: 2.447

Review 5.  Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016.

Authors:  Alessandro Lugli; Richard Kirsch; Yoichi Ajioka; Fred Bosman; Gieri Cathomas; Heather Dawson; Hala El Zimaity; Jean-François Fléjou; Tine Plato Hansen; Arndt Hartmann; Sanjay Kakar; Cord Langner; Iris Nagtegaal; Giacomo Puppa; Robert Riddell; Ari Ristimäki; Kieran Sheahan; Thomas Smyrk; Kenichi Sugihara; Benoît Terris; Hideki Ueno; Michael Vieth; Inti Zlobec; Phil Quirke
Journal:  Mod Pathol       Date:  2017-05-26       Impact factor: 7.842

6.  Identification of high-risk stage I colon and rectal cancer patients: a retrospective analysis of a large Japanese cohort.

Authors:  Yudai Fukui; Koya Hida; Nobuaki Hoshino; Daisuke Nishizaki; Ryosuke Okamura; Shinichi Yamauchi; Kenichi Sugihara; Yoshiharu Sakai
Journal:  Int J Colorectal Dis       Date:  2022-05-19       Impact factor: 2.796

7.  Improved outcomes and staging in non-small-cell lung cancer guided by a molecular assay.

Authors:  Alexander R Gupta; Gavitt A Woodard; David M Jablons; Michael J Mann; Johannes R Kratz
Journal:  Future Oncol       Date:  2021-08-26       Impact factor: 3.674

8.  Early detection of colorectal cancer, is it a guarantee for the cure of cancer?

Authors:  Kang Young Lee
Journal:  J Korean Soc Coloproctol       Date:  2012-02-29

Review 9.  The tumor border configuration of colorectal cancer as a histomorphological prognostic indicator.

Authors:  Viktor H Koelzer; Alessandro Lugli
Journal:  Front Oncol       Date:  2014-02-18       Impact factor: 6.244

10.  Clinical management of localized colon cancer with capecitabine.

Authors:  J Quidde; D Arnold; A Stein
Journal:  Clin Med Insights Oncol       Date:  2012-11-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.